2017
Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia
Azar MM, Assi R, Valika AK, Banach DB, Hall IE, Landry ML, Malinis MF. Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia. World Journal Of Transplantation 2017, 7: 269-275. PMID: 29104861, PMCID: PMC5661124, DOI: 10.5500/wjt.v7.i5.269.Peer-Reviewed Original ResearchRenal transplant recipientsGraft lossBK viremiaImmunosuppression reductionAcute rejectionEarly reductionTransplant recipientsPolymerase chain reactionCopies/Death-censored graft lossDeceased donor kidney transplantationKidney transplant recipientsDonor kidney transplantationRenal transplant biopsiesCopies/mLQuantitative polymerase chain reactionGraft functionKidney transplantationTransplant biopsiesMedian ageMonths 1PyVANBKV DNALower incidenceRetrospective analysis
2016
Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation
Azar MM, Malinis MF, Moss J, Formica RN, Villanueva MS. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation. International Journal Of STD & AIDS 2016, 28: 447-458. PMID: 27193421, DOI: 10.1177/0956462416651528.Peer-Reviewed Original ResearchConceptsInhibitor-based regimensRenal transplantationHIV/AIDSAntiretroviral regimenAntiretroviral therapyGraft survivalHIV-positive renal transplant recipientsEnd-stage renal diseaseHIV-positive patientsRenal transplant recipientsChronic kidney diseaseThree-year survivalInhibitor-based therapyNon-nucleoside reverseDrug-drug interactionsTransferase inhibitorsImmunosuppressive medicationsKidney transplantationTransplant recipientsAllograft rejectionGraft failureRenal diseaseCalcineurin inhibitorsClinical outcomesImmunosuppressive drugs